Skip to main content
Clinical Trials/DRKS00003369
DRKS00003369
Completed
未知

Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagus

HSK Wiesbaden0 sites60 target enrollmentNovember 29, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
C15.5
Sponsor
HSK Wiesbaden
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2011
End Date
November 1, 2014
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
HSK Wiesbaden

Eligibility Criteria

Inclusion Criteria

  • residual non\-neoplastic Barrett's mucosa in the distal esophagus of at least 1 cm extent longitudinally or radially. Informed consent.

Exclusion Criteria

  • poor healing after previous endoscopic therapy, such as endoscopic resection; relevant comorbidity; other exclusion criteria such as pregnancy, age below 18 years, coagulation disturbances, renal insufficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials